| 381 |
Improving medical certification of cause of death in Assiut University Children Hospital: an intervention study |
Department of Public Health and Community Medicine |
2024 |
| 382 |
In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial |
Department of Neurology and Psychiatry |
2024 |
| 383 |
Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia |
Department of Pharmacology |
2024 |
| 384 |
Interferon-induced transmembrane protein 3 (IFITM3) gene polymorphisms in COVID-19 patients in Assiut University Hospitals |
Department of Microbiology and Immunology |
2024 |
| 385 |
Internal ureteral stent versus percutaneous Nephrestomy tube in managment of acutely obstructed infected kidney in the presence of upper urinary tract stones: A prospective … |
Department of Urology |
2024 |
| 386 |
Interobserver reliability in the classification of thoracolumbar fractures using the AO spine TL injury classification system among 22 clinical experts in spine trauma care |
Department of Orthopedic Surgery and Traumatology |
2024 |
| 387 |
Intravenous ketorolac versus intravenous dexmedetomidine for postoperative analgesia after hypospadias repair |
Department of Anesthesia and Intensive Care |
2024 |
| 388 |
Left Internal Thoracic Artery versus Saphenous Vein Grafts to Left Anterior Descending Artery after Isolated Coronary Artery Bypass Surgery |
Department of Cardio-Thoracic Surgery |
2024 |
| 389 |
Light microscopical and parasitological analyses revealed the beneficial effects of silver nanoparticles and various myrrh extracts against Trichinella spiralis infection |
Department of Parasitology |
2024 |
| 390 |
Light microscopical and parasitological analyses revealed the beneficial effects of silver nanoparticles and various myrrh extracts against Trichinella spiralis infection in mice |
|
2024 |
Do you have any questions? 
